Volume : 6, Issue : 3, March - 2017
EFFECTIVENESS OF METFORMIN IN THE MANAGEMENT OF OBESITY AMONG ADULTS
Dr. Selvan. P, Dr. Jayasree. M, Dr. V. K. Sreekala, Dr. L. Vijayalekshmi
Abstract :
<p> <b style="text-align: justify;"><i>Introduction:</i></b><span style="text-align: justify;">Obesity and overweight are emerging health hazards.Current management is costly or intensive.Hence themanagement of obesity withMetformin has clinical significance.</span></p> <p class="MsoNormal" style="margin-top:12.0pt;text-align:justify;line-height: 150%"><o:p></o:p></p> <p class="MsoNormal" style="margin-top:12.0pt;text-align:justify;line-height: 150%"><b><i>Materials and methods:</i></b> The randomized control study was conducted on patients attending obesity clinic of the Department of Physical Medicine&Rehabilitation,Medical College Trivandrum.</p> <table cellpadding="0" cellspacing="0" width="100%"> <tbody> <tr> <td><!--[endif]--> <div> <p class="MsoNormal"><sup><span style="font-family:"Arial",sans-serif">2<o:p></o:p></span></sup></p> </div> <!--[if !mso]--></td> </tr> </tbody> </table> <p class="MsoNormal" style="margin-top:12.0pt;text-align:justify;line-height: 150%"><v:rect id="Rectangle_x0020_6" o:spid="_x0000_s1026" style="position:absolute;left:0;text-align:left;margin-left:259.15pt; margin-top:13.95pt;width:15pt;height:15.75pt;z-index:251664384;visibility:visible; mso-wrap-style:square;mso-width-percent:0;mso-height-percent:0; mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right:9pt; mso-wrap-distance-bottom:0;mso-position-horizontal:absolute; mso-position-horizontal-relative:text;mso-position-vertical:absolute; mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0; mso-width-relative:page;mso-height-relative:page;v-text-anchor:top" o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF dyTewfKKEqcMCKEmHfgZgaE8wMW+SSwc27JvS/v23KTJgkoXFsu+P+c7Ol5vDoMTe0zZBl/LVVlJ gV4HY31Xy4/tS3EvRSbwBlzwWMsjZrlprq/W22PELHjb51r2RPFBqax7HCCXIaLnThvSAMTP1KkI +gs6VLdVdad08ISeCho1ZLN+whZ2jsTzgcsnJwldluLxNDiyagkxOquB2Knae/OLUsyEkjenmdzb mG/YhlRnCWPnb8C898bRJGtQvEOiVxjYhtLOxs8AySiT4JuDystlVV4WPeM6tK3VaILeDZxIOSsu ti/jidNGNZ3/J08yC1dNv9v8AAAA//8DAFBLAwQUAAYACAAAACEArTA/8cEAAAAyAQAACwAAAF9y ZWxzLy5yZWxzhI/NCsIwEITvgu8Q9m7TehCRpr2I4FX0AdZk2wbbJGTj39ubi6AgeJtl2G9m6vYx jeJGka13CqqiBEFOe2Ndr+B03C3WIDihMzh6RwqexNA281l9oBFTfuLBBhaZ4ljBkFLYSMl6oAm5 8IFcdjofJ0z5jL0MqC/Yk1yW5UrGTwY0X0yxNwri3lQgjs+Qk/+zfddZTVuvrxO59CNCmoj3vCwj MfaUFOjRhrPHaN4Wv0VV5OYgm1p+LW1eAAAA//8DAFBLAwQUAAYACAAAACEAnQQOiKEDAADsCAAA HwAAAGNsaXBib2FyZC9kcmF3aW5ncy9kcmF3aW5nMS54bWy0VtuO2zYQfS/QfyD47rWklb2WEW3g a1Bgmy7WyQfQEmURpUiVpG8p+u89pO+7TQM0qRcLDzWjwzlnZki/e79rJNlwY4VWOY3vIkq4KnQp 1Cqnnz/NOwNKrGOqZFIrntM9t/T9488/vWPDlWFtLQoCBGWHLKe1c+2w27VFzRtm73TLFXyVNg1z WJpVtzRsC+RGdpMo6ncbJhR9vEBNmWNkbcR/gJK6+J2XE6Y2zAJSFsPrJ8ccZfH9yGyoNh9Mu2if jc+8+Lh5NkSUOYVyijWQiHaPjmMYlt1Xb60uALvKND5eVxXZ5TRNBvEg6lGyz+l9GkVp0jvg8Z0j BQLiLOpF2KtAAESMTv6i/u0bCEU9+1cMJHlIBsZVgrb16anNW8bJifELL9AiK8lJ/0z+FG7bJ5TG EqUnNWL4yBi9rTkrLbj4aOwGEQ/hQafLm1B2uf1VlxCVrZ0OrfJj9DpzZcPWWPeB64Z4I6cGXMJG bPNk3SG/U0gQQs+FlKHEUt08AObhCUqFV73PFy30859ZlM0Gs0HaSZP+rJNG02lnNJ+knf48fuhN 76eTyTT+y+8bp8NalCVXfpvTbMXpm8ZtRGG01ZW7K3TTRfeIgp/mC9MVR5fpslqK0sP5lKxZLSfS kA2TOZ2Hz7EKV2Hd2zRCkcDlFaU4SaNxknXm/cFDJ52nvU72EA06UZyNs36UZul0fkvpSSj+/ZTI NqdZD30f6HyVG2YDn7fc2LARjhsiRZPTwTmIDX1TzlQZSuuYkAf7Sgqf/kUKlPtUaJj2eB643SLM i9uNdbn3GS7xjUY2Gs2FucVZC6PW5gslW5ygObV/rJnhlMhfFGYii9MUYS4s0t5DgoW59iyvPUwV gMqpo+RgThxWeGXdGrGqsVMcZFJ6hAGqxLGhDzn57KR1C7eXPLAOmYMIaZh5CjAwXrwRpG6LMa+O 1rOzhxY6K3ztHVWhV2xb/FNc8EKzo2TGQxrsKnE+5JSrzucFLp0vyB0HHCVLZrmE9DgQQ0V9OK8q zOlhQEGCOaGI27e8YgXiRkYwSUnLlLZYRkk0jtCQ+D79pfAKV9Rz1ggZjlqcqDUzlocqBTU4u4L8 JBpuyUe+JS+6YeoGPAH4PU7lFP8JrNfgMe7QW3CQB2FPxD0m/gSEXP5ZoKbKZ2bYy1cF+Tb/H5ss 1P5fleBnwkEENKEX5Dw/a8sXrb9hUJTg8AMGw99L3Vf3fHAcf5f4HxPX68e/AQAA//8DAFBLAwQU AAYACAAAACEA4VE3H88GAADmGwAAGgAAAGNsaXBib2FyZC90aGVtZS90aGVtZTEueG1s7FnNb9xE FL8j8T+MfG+z381G3VTZzW4Dbdoo2Rb1OGvP2tOMPdbMbNK9ofaIhIQoiAOVuHFAQKVW4lL+mkAR FKn/Am9mbK8n65C0jaCC5pC1n3/zvt+8tX7sUMHRAhKU96Xv1izUMk8XlAk7Dn3RqPLqx6SCqc BJjxhPS8OZHelfX337uM13xG0wnHIhhHJCYIGCVyDfe8SKl0bWVF+kDG8iJPSQLfplzEWMGrCFcC gQ9BQMxWGrVaZyXGNPHWgaPSjIYM/iVKaoLPxJ5mQ1CCY5B+czqlPjHYYL+uEXIuB0ygA8x6HvAM +OGY3FMeYlgq+NDzaubPW1m/vILXskFMnTC2NG5k/rJx2YBgv2FkinBSCK2PWt1LmwV/A2BqGTcc DgfDesHPALDvg6VWlzLP1mi13s95lkD2cZn3oNautVx8iX9zSeduv99vdzNdLFMDso+tJfxqrdPa aDh4A7L49hK+1d8YDDoO3oAsvrOEH13qdlou3oAiRpP9JbQO6GiUcS8gU862KuGrAF+tZfAFCrKh yC4tYsoTdVKuxfguFyMAaCDDiiZIzVMyxT7k5ADHE0GxFoDXCC59sSRfLpG0LCR9QVPV8z5MceKV IC+fff/y2RN0dP/p0f2fjh48OLr/o2XkjNrCSVge9eLbz/589DH648k3Lx5+UY2XZfyvP3zyy8+f VwOhfBbmPf/y8W9PHz//6tPfv3tYAd8QeFKGj2lMJLpBDtEuj8Ew4xVXczIRrzZiHGFaHrGRhBIn WEup4D9UkYO+Mccsi46jR5+4HrwtoH1UAa/O7joK70VipmiF5GtR7AC3OWd9Liq9cE3LKrl5PEvC auFiVsbtYnxQJXuAEye+w1kKfTNPS8fwQUQcNXcYThQOSUIU0t/4PiEV1t2h1PHrNvUFl3yq0B2K +phWumRMJ042LQZt0RjiMq+yGeLt+Gb7NupzVmX1JjlwkVAVmFUoPybMceNVPFM4rmI5xjErO/w6 VlGVkntz4ZdxQ6kg0iFhHA0DImXVmJsC7C0F/RqGjlUZ9m02j12kUHS/iud1zHkZucn3BxGO0yrs Hk2iMvYDuQ8pitEOV1Xwbe5WiH6HOODkxHDfpsQJ9+nd4BYNHZUWCaK/zISOJbRqpwPHNPm7dswo 9GObA+fXjqEBPv/6UUVmva2NeAPmpKpK2DrWfk/CHW+6Ay4C+vb33E08S3YIpPnyxPOu5b5rud5/ vuWeVM9nbbSL3gptV68b7KLYLJHjE1fIU8rYnpozcl2aRbKEeSIYAVGPMztBUuyY0gges77u4EKB zRgkuPqIqmgvwikssOueZhLKjHUoUcolbOwMuZK3xsMiXdltYVtvGGw/kFht88CSm5qc7wsKNma2 Cc3mMxfU1AzOKqx5KWMKZr+OsLpW6szS6kY10+ocaYXJEMNl04BYeBMWIAiWLeDlDuzFtWjYmGBG Au13O/fmYTFROM8QyQgHJIuRtns5RnUTpDxXzEkA5E5FjPQm7xSvlaR1Nds3kHaWIJXFtU4Ql0fv TaKUZ/AiSrpuj5UjS8rFyRJ02PO67UbbQz5Oe94U9rTwGKcQdanXfJiFcBrkK2HT/tRiNlW+iGY3 N8wtgjocU1i/Lxns9IFUSLWJZWRTw3zKUoAlWpLVv9EGt56XATbTX0OL5iokw7+mBfjRDS2ZTomv ysEuUbTv7GvWSvlMEbEXBYdowmZiF0P4daqCPQGVcDRhOoJ+gXM07W3zyW3OWdGVT68MztIxSyOc tVtdonklW7ip40IH81ZSD2yr1N0Y9+qmmJI/J1PKafw/M0XPJ3BS0Ax0BHw4lBUY6XrteVyoiEMX SiPqjwQsHEzvgGyBs1j4DEkFJ8jmV5AD/WtrzvIwZQ0bPrVLQyQozEcqEoTsQFsy2XcKs3o2d1mW LGNkMqqkrkyt2hNyQNhY98COnts9FEGqm26StQGDO55/7ntWQZNQL3LK9eb0kGLutTXwT698bDGD UW4fNgua3P+FihWzqh1vhudzb9kQ/WGxzGrlVQHCSlNBNyv711ThFada27GWLG60c+UgissWA7FY EKVw3oP0P5j/qPCZvW3QE+qY70JvRXDRoJlB2kBWX7ALD6QbpCVOYOFkiTaZNCvr2mzppL2WT9bn vNIt5B5zttbsLPF+RWcXizNXnFOL5+nszMOOry3tRFdDZI+XKJCm+UbGBKbq1mkbp2gS1nse3PxA oO/BE9wdeUBraFpD0+AJLoRgsWRvcXpe9pBT4LulFJhmTmnmmFZOaeWUdk6BxVl2X5JTOtCp9BUH XLHpHw/ltxmwgstuP/Km6lzNrf8FAAD//wMAUEsDBBQABgAIAAAAIQCcZkZBuwAAACQBAAAqAAAA Y2xpcGJvYXJkL2RyYXdpbmdzL19yZWxzL2RyYXdpbmcxLnhtbC5yZWxzhI/NCsIwEITvgu8Q9m7S ehCRJr2I0KvUBwjJNi02PyRR7Nsb6EVB8LIws+w3s037sjN5YkyTdxxqWgFBp7yenOFw6y+7I5CU pdNy9g45LJigFdtNc8VZ5nKUxikkUigucRhzDifGkhrRykR9QFc2g49W5iKjYUGquzTI9lV1YPGT AeKLSTrNIXa6BtIvoST/Z/thmBSevXpYdPlHBMulFxagjAYzB0pXZ501LV2BiYZ9/SbeAAAA//8D AFBLAQItABQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAAAAAAAAAAAAAAAAAAABbQ29udGVudF9U eXBlc10ueG1sUEsBAi0AFAAGAAgAAAAhAK0wP/HBAAAAMgEAAAsAAAAAAAAAAAAAAAAANgEAAF9y ZWxzLy5yZWxzUEsBAi0AFAAGAAgAAAAhAJ0EDoihAwAA7AgAAB8AAAAAAAAAAAAAAAAAIAIAAGNs aXBib2FyZC9kcmF3aW5ncy9kcmF3aW5nMS54bWxQSwECLQAUAAYACAAAACEA4VE3H88GAADmGwAA GgAAAAAAAAAAAAAAAAD+BQAAY2xpcGJvYXJkL3RoZW1lL3RoZW1lMS54bWxQSwECLQAUAAYACAAA ACEAnGZGQbsAAAAkAQAAKgAAAAAAAAAAAAAAAAAFDQAAY2xpcGJvYXJkL2RyYXdpbmdzL19yZWxz L2RyYXdpbmcxLnhtbC5yZWxzUEsFBgAAAAAFAAUAZwEAAAgOAAAAAA== " filled="f" stroked="f"> <v:textbox> <!--[if !mso]--> <!--[endif]--></v:textbox> </v:rect>Patients are randomly assigned to two groups .Group I –<b>Life Style Intervention</b> alone &.<b>.</b>Group II – <b>Metformin </b>1000mg. sustained release tablet daily orally for six months along with <b>Life Style Intervention</b>.<o:p></o:p></p> <p class="MsoNormal" style="margin-top:12.0pt;text-align:justify;line-height: 150%"><o:p> </o:p></p> <p class="MsoNormal" style="text-align:justify;line-height:150%;mso-layout-grid-align: none;text-autospace:none"><b><i>Results:</i></b><span lang="EN-IN">There is a significant reduction in the weight, BMI and fat percentage without hypoglycaemic effect in the metformin group when compared to the control group. <o:p></o:p></span></p> <p class="MsoNormal" style="text-align:justify;line-height:150%;mso-layout-grid-align: none;text-autospace:none"><span lang="EN-IN">.<o:p></o:p></span></p> <p class="MsoNormal" style="text-align:justify;line-height:150%;mso-layout-grid-align: none;text-autospace:none"><b><i>Conclusion:</i></b><span lang="EN-IN">Metformin can be considered in the treatment of obesity<o:p></o:p></span></p>
Keywords :
Cite This Article:
Dr.Selvan.P, Dr.Jayasree.M, Dr.V.K.Sreekala, Dr.L. Vijayalekshmi, EFFECTIVENESS OF METFORMIN IN THE MANAGEMENT OF OBESITY AMONG ADULTS, GLOBAL JOURNAL FOR RESEARCH ANALYSIS : Volume-6, Issue-3, March‾2017